Showing results (601-610 of 2,903) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|January 24, 2015
Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinaseH Stedt, H Samaranayake, J Kurkipuro, et al.Cancer Gene Therapy|April 10, 2021
Cancer immunotherapies revisited: state of the art of conventional treatments and next-generation nanomedicinesCoral García-Fernández, Anna Saz, Cristina Fornaguera, et al.Cancer Gene Therapy|August 25, 2012
A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumorsB G Wieking, D W Vermeer, W C Spanos, et al.Cancer Gene Therapy|October 20, 2012
Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapyA Pacholska, T Wirth, H Samaranayake, et al.Cancer Gene Therapy|October 13, 2012
Will T-cell therapy for cancer ever be a standard of care?M K BrennerCancer Gene Therapy|January 4, 2014
Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infectionP R A Buijs, C H J van Eijck, L J Hofland, et al.Cancer Gene Therapy|June 28, 2014
Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognitionA B Del Campo, J Carretero, J A Muñoz, et al.Cancer Gene Therapy|May 24, 2014
The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cellsS Yan, X Yang, T Chen, et al.Cancer Gene Therapy|February 28, 2015
Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studiesW H Shuen, R Kan, Z Yu, et al.Cancer Gene Therapy|February 28, 2015
Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancerZ Zhang, J Huang, C Zhang, et al.Pageof 291